(Q46051734)

19 December 2017

title

Viruses: tools for tumor target discovery, and agents for oncolytic therapies - an introduction (English)

1 reference

19 December 2017

1 reference

Clodagh C O'Shea

1

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

19 December 2017

published in

Oncogene

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

52

1 reference

19 December 2017

page(s)

7636-7639

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209035

exact match

0 references

cites work

Oncolytic viral therapies - the clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Involvement of PP2A in viral and cellular transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

VSV-tumor selective replication and protein translation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Modulation of cell function by small transmembrane proteins modeled on the bovine papillomavirus E5 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Development of transcriptionally regulated oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Oncolytic adenoviruses - selective retargeting to tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Future prospects for oncolytic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Viruses - seeking and destroying the tumor program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Retroviral insertional mutagenesis: past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Inactivating intracellular antiviral responses during adenovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209035

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209035

1 reference

19 December 2017

1 reference

19 December 2017